Basic information

CPKB ID CP00305
IUPAC Name
(3S,8aS)-3-(1H-imidazol-5-ylmethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Synonyms
Function

Anti-Inflammatory   Dopamine Uptake Inhibitor   PubChem  

Information

Cyclo(L-His-L-Pro) is a homodetic cyclic peptide resulting from the formal condensation of both the amino and acid groups of L-histidine with the acid and amino groups of L-proline. It is a metabolite of thyrotropin-releasing hormone (TRH). It has a role as a human blood serum metabolite, a dopamine uptake inhibitor and an anti-inflammatory agent. It is a homodetic cyclic peptide, a dipeptide, a pyrrolopyrazine and a member of imidazoles. It is functionally related to a L-histidine and a L-proline.

PubChem|449094   DrugBank|DB02414  

Legend

Structure

similarity structure
Molecular Formula

C11H14N4O2

Molecular Weight 234.1116757 g/mol
SMILES

RUN SEA Predictions

O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCC[C@@H]12  

PubChem|449094

InChI
InChI=1S/C11H14N4O2/c16-10-9-2-1-3-15(9)11(17)8(14-10)4-7-5-12-6-13-7/h5-6,8-9H,1-4H2,(H,12,13)(H,14,16)/t8-,9-/m0/s1  
InChIKey
NAKUGCPAQTUSBE-NPOCPZDKNA-N
2D Structure
PubChem|449094
3D Structure
PubChem|449094
3D Structure (Complex)
PDB|1W1T  PDB|3N1A 

Sequence

Graph alignment
Local alignment
One letter code from Structure
HP  

CyclicPepedia|Struct2seq

Amino acid chain from Structure
His--Pro  

CyclicPepedia|Struct2seq

Description of the conversion sequence The one letter code and Amino acid chain derived from the structural transformation may be inconsistent, with the Amino acid chain containing Essential Amino acid and the one letter code not.

Chemical and Physical Properties

CyclicPepedia|Struc2Seq + PP

Structure Properties

Property Name Property Value
Exact Mass 234.1116757
Number of Rings 3.0
Complexity 1.470588235
XlogP3 AA -0.5584
Heavy Atom Count 17.0
Hydrogen Bond Donor Count 2.0
Hydrogen Bond Acceptor Count 3.0
Rotatable Bond Count 2.0
Property Name Property Value
Formal Charge 0.0
Refractivity 58.9574
Rule_of_Five 1.0
Number of Atoms 17.0
Topological Polar Surface Area 78.09
Refractivity 58.9574
Veber Rule 1.0
Ghose Filter 0.0

Property Name Property Value
RDKit Fingerprint
11001111010000000100101011011000010000100111010001101010011000000010101101101000110111010010110010010100100001001000000000110000000001011000111000001101110110100100001010000010000110011111100100010000101001001000010010000000000100000100001110011000011110101111001110001000001010001001000000100000111010011001001000010001011100000000001011010100101100010010011100000001000010000000010100000010010100000000000100101110001010100000101001110001100011000100000100010010011000110001100000000010000011010101100000100100110000000100100110010101000110000100110010000100011100100100010010000000000000111000101110100001000010011000000000001001011000100110000110100110100010000110011100000100010110011101011100010001000001000001100100100011001000111000101010000000001100101001101110010010000001100001001000001000001000111010000000100001111000011010011111101001000000100010001001010001000100100100111000000011000101010010111000000100011100011010000001010110000000000100011001010000011001010000001101001001110101000000000000001100001101110011110101001010100000001010000000001000001101100001001000011101110110100001001011011110000000001000000110001011010011000000101000001000100110100110101111011010010001001111100001000100000001011110010110100010011100010110000110010000100100001010001000101000000000100000110101101001011010100001000000100000100000001001101110000011010110110001010000010010001101001000000000000000000000001100000001000000100010110010000011111110001000001011000100000100010000100001010010111111111001000100100100100110000000100000000000110001000000100000000010100000000100100110101001010101100010010001000110000001010010100010110000000100100000101110010000000001000010000101101010100001000100100110111110000100100001000001010110000000100000100011011001010110000110010010100000000010101001010010000000000001111001000100000010100000011110100110010011000011100001010100110001100101010000001001101100001101101101100001010010010011010011000111000110000011011001001000000000000001001001100110101101000000110000000000000001101010000100010000101000000111
Morgan Fingerprint
0000110000100000000100000000100000000000000000000000000000000000000000000000000010000000001000100000000000000000000100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001000000000000000000000000000000000000000000000000110000001000000000000100000000000010000000000000000000000000100000000000000010000000000000000000001000000000000000000000000000000000000000000000000000000000000000000010000000001010000000000000000000000000000000000000000000000001000100000000000000000000000000000000000000000000000000000000000000000001000000000000000000000000000000000000000000000000000000100000000000000010000000000000010000000000000000001000000000000000000000000000010000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000010000100000000000000000000000000000000000001000000000000000001000000000000000000000000100000000000000000000000001000000010000000010000000000000000000000000000000000000100000000000000000000000000000000000000000000010000
MACCS Keys
00000000000000000000000000000000000000000000000000000100000000000100000000000101100101000011100110101100110000110000011011100001110100001100001100011011011110110111110

Sequence Properties

Property Name Property Value
Boman Index 2.33
Charge 0.088893390301838

Manufacturers

Manufacturers Name Value
CreativePeptides
Bayer healthcare pharmaceuticals
Upsher smith laboratories
Merck
Manufacturers Name Value
Apotex
Baxter Healthcare Corp
Pharmasources
Novartis
AstraZeneca

Forecasting tools

Forecasting tools Value
Structure to Sequence
Structure Properties
Sequence to Structure
HP
Sequence Properties
HP
Expasy ProtParam Tool HP
SEA RUN SEA Predictions

Information Source

Property Name Property ID
Patents NAKUGCPAQTUSBE-NPOCPZDKNA-N
pubchem 449094
Drugbank DB02414
DRAMP3
Uniprot
Cybase
CONOSERVER
BindingDB
CHEMBL CHEMBL188225
CTD
Wikipedia
KEGG Compound/Drug
CHEBI CHEBI:90039
EPA DSSTox DTXSID90962567
FDA Global Substance Registration System (GSRS) Q10817UXVT
DTP/NCI
Chemspider 395717

Reference

Pubmed_ID Title DOI Journal

2050791

Isolation of bacitracins A and F by high-speed counter-current chromatography 10.1016/s0021-9673(01)91638-3.

J Chromatogr

Isolation of bacitracins A and F by high-speed counter-current chromatography

Abstract

  • The major components of bacitracin were separated and purified using high-speed counter-current chromatography (HSCCC). A systematic search for optimum two-phase solvent systems resulted in two systems: chloroform-ethanol-methanol-water (5:3:3:4) and chloroform-ethanol-water (5:4:3). These were selected based on the determination of the partition coefficients of all the components and the settling time of the phases. HSCCC with these solvent systems separated two components, bacitracins A and F. Improvements in the flow-cell arrangement eliminated noise in detection, making in-line monitoring possible. A tandem mass spectrometric technique was used to characterize the isolated components.

6625543

Sporulation in Bacillus licheniformis during altered bacitracin synthesis

None

Antibiotiki

Sporulation in Bacillus licheniformis during altered bacitracin synthesis

Abstract

  • Sporulation in different strains of Bacillus licheniformis, 10716 and 1001 in connection with changes in synthesis of bacitracin was studied. It was shown that the sporulation efficiency did not depend on the synthesis of the antibiotic: in some strains with low potency for the antibiotic production, the sporulation level was lowered, while in the others, it was not lowered. Moreover, normal sporulation was also observed, when the synthesis of bacitracin was inhibited. Therefore, it is suggested that there is no correlation between the sporulation and antibiotic production.

7155141

Physico-chemical properties of the complexes of bacitracin with DNA and its effect on the process of transcription in vitro

None

Mol Biol (Mosk)

Physico-chemical properties of the complexes of bacitracin with DNA and its effect on the process of transcription in vitro

Abstract

  • The aim of the present paper was to study the action of one of the peptide antibiotics, bacitracin, as the regulator of gene activity at the transcription level. Therefore the commercial bacitracin has been fractionated into two main parts by paper chromotography. These two fractions have been identified as bacitracin A (biologically active) and bacitracin F (biologically inactive). The binding of both fractions to DNA has been studied. It has been shown that bacitracin A stabilizes DNA to a lesser degree than bacitracin F does. DNA-bacitracin complexes are formed in the major groove of the DNA helix by hydrogen bonds. The analysis of the the obtained experimental data allows us to suppose that bacitracin binding to DNA has a very specific character and that this antibiotic may act as the regulator of gene activity.